ArticleExperimental and therapeutic medicine2019

Combination of metformin and p38 MAPK inhibitor, SB203580, reduced myocardial ischemia/reperfusion injury in non-obese type 2 diabetic Goto-Kakizaki rats.

Jantira Sanit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.